Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.01

+0.07 (+3.61%)

As of Apr 1, 3:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,395.0% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $2.01

Current
$2.01

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

1,000.5%

Low target

Base Case

$30.05

+1,395.0%

Avg target

Bull Case

$38.96

+1,838.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-53.7% from high

52-Week Low

$1.41

+42.6% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%